Dipyridamole, chloroquine, montelukast sodium, candesartan, oxytetracycline, and atazanavir are not SARS-CoV-2 main protease inhibitors

Proc Natl Acad Sci U S A. 2021 Feb 23;118(8):e2024420118. doi: 10.1073/pnas.2024420118.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acetates
  • Atazanavir Sulfate
  • Benzimidazoles
  • Biphenyl Compounds
  • COVID-19 Drug Treatment*
  • Chloroquine
  • Cyclopropanes
  • Dipyridamole
  • Humans
  • Oxytetracycline*
  • Pharmaceutical Preparations*
  • Protease Inhibitors
  • Quinolines
  • SARS-CoV-2
  • Sulfides
  • Tetrazoles

Substances

  • Acetates
  • Benzimidazoles
  • Biphenyl Compounds
  • Cyclopropanes
  • Pharmaceutical Preparations
  • Protease Inhibitors
  • Quinolines
  • Sulfides
  • Tetrazoles
  • Atazanavir Sulfate
  • Dipyridamole
  • Chloroquine
  • montelukast
  • candesartan
  • Oxytetracycline